QQQ $ 435.98 $ 3.66 (0.85 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.22 (1.23 %)
TLT $ 89.88 $ -0.23 (-0.26 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.019
-- x --
-- x --
-- - --
$ 0.02 - $ 0.06
156,059
na
na
$ 1.25
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psyched-canadas-case-for-psilocybin-access-and-microdose-trial-us-reform-update-battle-with-dea--more

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsui...

 mdma-transdermal-patch-moves-toward-first-in-human-trials-latest-development-update

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and develo...

 meth-use-disorder-tackled-with-psilocybin-clinical-trial-begins-patient-enrollment

Life sciences company Revive Therapeutics Ltd.

 psyched-12-states-discuss-legalization-bills-ceremonies-for-veterans-with-tbi-ketamine-and-mdma-fast-tracks--more

Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More

 mdma-news-optimis-new-drug-now-available-revive-advances-transdermal-patch-evaluations

Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental...

 pharmather-holdings-nabs-new-orphan-drug-status-discusses-further-fast-track-partners-for-mdma-patch

Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company&...

 psyched-psychedelics-in-davos-prince-harry-in-the-90s-cathie-woods-latest-moves-and-more

Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second ...

 psychedelics-company-revive-raises-32m-to-target-infectious-diseases-disorders

Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, inc...

 psyched-first-ayahuasca-pill-created-psychedelics-legalization-predicted-uks-research-support-and-more

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedel...

 psyence-revive-therapeutics-ink-private-placements-capital-to-support-drug-trials

Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private place...

 revive-therapeutics-to-raise-up-to-5m-via-private-placement

REVIVE THERAPEUTICS LTD. (OTCQB: RVVTF) (CSE:RVV) announced that it is arranging a private placement of a minimum of $3 million...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION